Clinical Trial Update: Study of Recombinant Human N-acetylgalactosamine 4-sulfatase (rhASB) in Patients With MPS VI [Phase 3]

View source ↗

Summary

A Phase 3 trial of recombinant human N-acetylgalactosamine 4-sulfatase (galsulfase) for mucopolysaccharidosis type VI has completed and results were posted in 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mucopolysaccharidosis Type Vi

Drugs mentioned

• Galsulfase (recombinant human N-acetylgalactosamine 4-sulfatase (rhASB))

Snippet

Sponsor: BioMarin Pharmaceutical | Conditions: Mucopolysaccharidosis VI | Phase 3 | Status: COMPLETED | Results posted: 2009-08-17